PIL - Salbutamol 2.5mg/2.5ml, 5mg/2.5ml Nebuliser solution: Change history
View Patient Information Leaflet (PIL - Salbutamol 2.5mg/2.5ml, 5mg/2.5ml Nebuliser solution)
Last updated on this site: 30 Oct 2025
Update in line with MHRA request to add sleep disturbances as a side effect to section 4.8 of the product SmPC, and to section 4 of the product PIL.
Additional editorial amends in the PIL.
SPC sections updated: 4.8 and 10
View Patient Information Leaflet (PIL - Salbutamol 2.5mg/2.5ml, 5mg/2.5ml Nebuliser solution)
Last updated on this site: 30 Oct 2025
Update in line with MHRA request to add sleep disturbances as a side effect to section 4.8 of the product SmPC, and to section 4 of the product PIL.
Additional editorial amends in the PIL.
SPC sections updated: 4.8 and 10
-
Changes: (Updated: 30 Oct 2025)
Update in line with MHRA request to add sleep disturbances as a side effect to section 4.8 of the product SmPC, and to section 4 of the product PIL.
Additional editorial amends in the PIL.
SPC sections updated: 4.8 and 10
-
Changes: (Updated: 15 Jul 2024)
To update section 4.4 of the SmPC and PIL for Salbutamol 2.5mg/2.5ml Nebuliser Solution and Salbutamol 5mg/2.5ml to bring in line with the reference products Ventolin Nebules 2.5mg and 5mg by MAH., Glaxo Wellcome UK Ltd., (PL10949/0085-0086).
-
Changes: (Updated: 22 Sep 2022)
Initial upload